Clinical Trial Update: AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an everolimus-eluting stent for chronic total occlusions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Total Occlusion of the Coronary Artery

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: North Texas Veterans Healthcare System | Conditions: Coronary Occlusions | Phase 4 | Status: COMPLETED